Myrtle S Potter is Director of Urovant Sciences Ltd.. Currently has a direct ownership of 0 shares of UROV, which is worth approximately $0. The most recent transaction as insider was on Mar 29, 2021, when has been sold 21,480 shares (Common Shares) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
0% 3M change
0% 12M change
Total Value Held $0

MYRTLE S POTTER Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 29 2021
SELL
Sale (or disposition) back to the issuer
-
21,480 Reduced 100.0%
0 Common Shares

Also insider at

RAD
RITE AID CORP Healthcare
MYOV
Myovant Sciences Ltd. Healthcare
GH
Guardant Health, Inc. Healthcare
DNA
Ginkgo Bioworks Holdings, Inc. Healthcare
MSP

Myrtle S Potter

Director
Camp Hill, PA

Track Institutional and Insider Activities on UROV

Follow Urovant Sciences Ltd. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells UROV shares.

Notify only if

Insider Trading

Get notified when an Urovant Sciences Ltd. insider buys or sells UROV shares.

Notify only if

News

Receive news related to Urovant Sciences Ltd.

Track Activities on UROV